Literature DB >> 16645965

Methotrexate pharmacogenetics: the first step toward individualized therapy in rheumatoid arthritis.

Prabha Ranganathan1, Howard L McLeod.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16645965     DOI： 10.1002/art.21762

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  37 in total

1.  Therapy: methotrexate guidelines: compromise to reach consensus.

Authors:  Joel M Kremer
Journal:  Nat Rev Rheumatol       Date:  2009-04       Impact factor: 20.543

2.  Monotherapy with methotrexate for primary central nervous lymphoma has single agent activity in the absence of radiotherapy: a single institution cohort.

Authors:  Julien Cobert; Ephraim Hochberg; Nina Woldenberg; Fred Hochberg
Journal:  J Neurooncol       Date:  2009-12-18       Impact factor: 4.130

Review 3.  Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?

Authors:  Heinrike Schmeling; Gerd Horneff; Susanne M Benseler; Marvin J Fritzler
Journal:  Nat Rev Rheumatol       Date:  2014-08-12       Impact factor: 20.543

4.  TLR signaling modulates side effects of anticancer therapy in the small intestine.

Authors:  Magdalena Frank; Eva Maria Hennenberg; Annette Eyking; Michael Rünzi; Guido Gerken; Paul Scott; Julian Parkhill; Alan W Walker; Elke Cario
Journal:  J Immunol       Date:  2015-01-14       Impact factor: 5.422

5.  Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis.

Authors:  L A Davis; B Polk; A Mann; R K Wolff; G S Kerr; A M Reimold; G W Cannon; T R Mikuls; L Caplan
Journal:  Clin Exp Rheumatol       Date:  2014-01-20       Impact factor: 4.473

6.  Nonassociation of homocysteine gene polymorphisms with treatment outcome in South Indian Tamil Rheumatoid Arthritis patients.

Authors:  Niveditha Muralidharan; Reena Gulati; Durga Prasanna Misra; Vir S Negi
Journal:  Clin Exp Med       Date:  2017-08-18       Impact factor: 3.984

7.  The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies.

Authors:  Angela Su; Frank Ling; Camille Lobry; Kris C Wood; Raphael Itzykson; Alexandre Puissant; Camille Vaganay; Gaetano Sodaro; Chaïma Benaksas; Reinaldo Dal Bello; Antoine Forget; Bryann Pardieu; Kevin H Lin; Justine C Rutter; Christopher F Bassil; Gael Fortin; Justine Pasanisi; Iléana Antony-Debré; Gabriela Alexe; Jean-François Benoist; Alain Pruvost; Yana Pikman; Jun Qi; Marie-Hélène Schlageter; Jean-Baptiste Micol; Giovanni Roti; Thomas Cluzeau; Hervé Dombret; Claude Preudhomme; Nina Fenouille; Lina Benajiba; Hava M Golan; Kimberly Stegmaier
Journal:  Cancer Discov       Date:  2020-08-21       Impact factor: 39.397

8.  (1)H NMR-based metabolomic analysis for identifying serum biomarkers to evaluate methotrexate treatment in patients with early rheumatoid arthritis.

Authors:  Zhigang Wang; Zhe Chen; Sisi Yang; Yu Wang; Lifang Yu; Bicheng Zhang; Zhiguo Rao; Jianfei Gao; Shenghao Tu
Journal:  Exp Ther Med       Date:  2012-05-03       Impact factor: 2.447

9.  The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis.

Authors:  Jaroslav Chládek; Marie Simková; Jaroslava Vanecková; Milos Hroch; Jirina Chládkova; Jirina Martínková; Jaroslava Vávrová; Martin Beránek
Journal:  Eur J Clin Pharmacol       Date:  2007-12-29       Impact factor: 2.953

10.  Are Thymidylate synthase and Methylene tetrahydrofolate reductase genes linked with methotrexate response (efficacy, toxicity) in Indian (Asian) rheumatoid arthritis patients?

Authors:  Yogita Ghodke; Arvind Chopra; Kalpana Joshi; Bhushan Patwardhan
Journal:  Clin Rheumatol       Date:  2008-02-15       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.